Back to mobile site

More on ELAB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (12/24/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PMGC Holdings (NQ:ELAB)
Delayed: 5.21 -0.02 (0.38%)
Prev. Close $5.23  
Open$5.17 
52 Wk High$ 
52 Wk Low$ 
Day High$5.35 
Day Low$5.17 
P/E N/A  
EPS$ 
Volume16,122 

Friends, Peers and Foes (?): CITR NTHI (more...)

Sep 1, 2026 07:49 AM NorthStrive expands drug discovery deal with Yuva Biosciences
Sep 1, 2026 07:45 AM NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Th
Aug 27, 2026 05:26 PM Form 8-K PMGC Holdings Inc. For: Aug 21
Aug 26, 2026 08:18 AM PMGC Holdings drops Arizona acquisition after due diligence review
Aug 26, 2026 08:17 AM PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing
Aug 26, 2026 08:17 AM PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfol
Aug 25, 2026 07:32 AM PMGC Holdings signs term sheet with Orbit2Orbit for space muscle study
Aug 25, 2026 07:30 AM PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus
Aug 21, 2026 09:30 AM NorthStrive files two patents for muscle-loss drugs in spaceflight
Aug 21, 2026 09:30 AM NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
View All Articles

Entities mentioned with ELAB

View All Entities